FDA Halts Use of Most Monoclonal Antibodies for COVID Treatment

The monoclonal antibody combinations bamlanivimab/etesevimab and casirivimab/imdevimab (REGEN-COV) should only be used for COVID-19 patients exposed to variants other than Omicron, the FDA said on Monday.

The agency revised the emergency use authorization (EUA) for the two antibody cocktails for use “only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments,” Patrizia Cavazzoni, MD, director of the FDA’s Center for Drug Evaluation and Research, said in the statement.

FDA cited “markedly reduced activity against the Omicron variant” as the reason for this revision. In addition, because CDC data indicate that over 99% of U.S. COVID cases are from Omicron, “it’s highly unlikely that COVID-19 patients … are infected with a variant other than Omicron, and these treatments are not authorized to be used at this time,” Cavazzoni added.

This action by the agency formalizes the recommendation made at the end of December by the NIH COVID Treatment Guidelines panel, which advised against the use of any monoclonal antibody treatment, with the exception of sotrovimab for high-risk COVID patients, as it was the only one with in vitro efficacy against Omicron.

FDA recommended sotrovimab and other non-monoclonal antibody therapies for outpatients at high risk of progressing to severe COVID, such as oral antiviral nirmatrelvir-ritonavir (Paxlovid), intravenous antiviral remdesivir (Veklury), and oral antiviral molnupiravir, which are “expected to work” against Omicron and are authorized for this high-risk patient population with mild to moderate COVID-19, according to Cavazzoni.

The agency noted that this action avoids exposing patients to side effects, some potentially serious, such as injection site reactions or allergic reactions from a treatment that “is not expected to provide benefit” against Omicron.

  • author['full_name']

    Molly Walker is deputy managing editor and covers infectious diseases for MedPage Today. She is a 2020 J2 Achievement Award winner for her COVID-19 coverage. Follow

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
7 Upcoming Motorcycle Launches In August  thumbnail

7 Upcoming Motorcycle Launches In August 

Along with the monsoon, it looks like it’ll be raining motorcycles this month. August is set to witness an onslaught of two-wheeler launches, ranging from a new Royal Enfield motorcycle to a couple of Ducatis. Here’s the full list. 1. Royal Enfield Hunter 350 Starting with the first week of August, Royal Enfield will finally…
Read More
ZZTEST FEAT Allergy Tips for Outdoor Living thumbnail

ZZTEST FEAT Allergy Tips for Outdoor Living

Please enable cookies. Error 1005 Ray ID: 800ac964bc9c8a08 • 2023-09-03 03:08:10 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 800ac964bc9c8a08 • Your IP: •
Read More
Aishwarya Rai appears before ED in Panama Papers case thumbnail

Aishwarya Rai appears before ED in Panama Papers case

Bollywood actor Aishwarya Rai Bachchan on Monday appeared before the Enforcement Directorate in Delhi in connection with the Panama Papers case. Aishwarya Rai Bachchan's name featured in the list of 500 Indians in the Panama Papers leak. (File photo)Bollywood actor Aishwarya Rai Bachchan on Monday appeared before the Enforcement Directorate (ED) in connection with the…
Read More
WHO/Europe launches New Economics Expert Group to advance health equity thumbnail

WHO/Europe launches New Economics Expert Group to advance health equity

WHO/Europe, through the WHO European Office for Investment for Health and Development, based in Venice, Italy, has launched a New Economics Expert Group (NEEG) comprised of representatives and research specialists from 14 institutions. The group will work to facilitate the implementation of the WHO resolution on accelerating progress towards healthy, prosperous lives for all in…
Read More
Move Over, G Spot - thumbnail

Move Over, G Spot –

Feb. 1, 2022 -- The G spot, an area inside the vagina that's thought to cause exceptional sexual pleasure, can be difficult to pinpoint. Now, researchers are focused instead on finding an even more elusive sweet spot related to women's sexual pleasure: the part of the brain that responds to genital touch.The findings about the…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?